National institute of virology - india council of medical research - Latest News Update, Information, Photos & Videos on National institute of virology - india council of medical research at Lokmat Times

Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufacturer informed on Sunday.As per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared to the vaccine variant (D614G).It however added that despite this reduction, neutralizing titre levels with B.!.617 remain above levels expected to be protective."No difference in neutralization between B.1.1.7 (first found in the UK) and vaccine strain (D614G) was observed," Bharat Biotech added.These findings are from a study conducted in collaboration with the National Institute of Virology - India Council of Medical Research.COVAXIN is one of the three COVID-19 vaccines that are currently available in the country.As per the Union Health Ministry, a total of 18,22,20,164 doses of COVID-19 vaccines have been administered across the country so far.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

National Institute Of Virology - India Council Of Medical ResearchFOLLOW

National institute of virology - india council of medical research, Latest News

National :COVAXIN effective against coronavirus strains found in India, UK

Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine ...